Indeed, the combination of anti-cathepsin with taxol treatment enhances the anti-tumor efficacy, the late-stage survival and decreases the metastatic burden compared to taxol alone in a breast cancer mouse model [97]. Here, CTSS is linked to breast carcinoma.